0001209191-23-032276.txt : 20230525 0001209191-23-032276.hdr.sgml : 20230525 20230525183732 ACCESSION NUMBER: 0001209191-23-032276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230524 FILED AS OF DATE: 20230525 DATE AS OF CHANGE: 20230525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kersten Dirk CENTRAL INDEX KEY: 0001823682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 23962461 MAIL ADDRESS: STREET 1: C/O FORBION CAPITAL FUND IV COOPERATIEF STREET 2: GOOMIER 2-35 CITY: NAARDEN STATE: P7 ZIP: 14111 DC ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-24 0 0001818794 Dyne Therapeutics, Inc. DYN 0001823682 Kersten Dirk C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD WALTHAM MA 02451 1 0 1 0 0 Stock Option (right to buy) 13.49 2023-05-24 4 A 0 24900 0.00 A 2033-05-23 Common Stock 24900 24900 D This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders. /s/ Richard Scalzo, Attorney-in-Fact 2023-05-25